eau
model
ocular
inflammatori
diseas
eau
resembl
anoth
cellmedi
autoimmun
diseaseexperiment
allerg
encephalomyelitissinc
increas
express
mhc
class
ii
molecul
target
tissu
adopt
transfer
activ
cell
inhibit
cyclosporin
immunolog
find
compar
find
cellular
mechan
involv
diseas
eau
induc
immun
purifi
retin
protein
eau
rat
good
experiment
model
posterior
peptid
fragment
emulsifi
freund
complet
uveiti
man
due
similar
patholog
adjuv
fca
commonli
use
uveitogen
retin
diseas
process
function
bloodretin
solubl
antigen
sag
intracellular
protein
exist
barrier
rat
man
eau
infiltr
lymphocyt
rod
outer
segment
pineal
gland
howev
two
mainli
cell
appear
within
retina
earli
purifi
proteinsinterphotoreceptor
retinoid
bind
diseas
result
irrevers
destruct
photoreprotein
irbp
rhodopsinhav
also
found
ceptor
cell
loss
integr
retin
layer
uveitogen
speci
synthet
peptid
made
throughout
diseas
increas
express
molecul
uveitogen
studi
eau
mhc
class
ii
molecul
varieti
retin
cell
later
induc
sag
peptid
allow
identif
highli
stage
diseas
increas
number
cell
seen
pathogen
epitop
within
whole
antigen
recent
within
retina
propos
cell
could
studi
irbp
found
epitop
molecul
downregul
diseas
process
import
highli
uveitogen
necessarili
stimulatori
cell
cell
eau
first
demonstr
lewi
rat
vitro
also
found
uveitopathogen
diseas
success
induc
naiv
recipi
adoptiregion
sag
share
sequenc
homolog
varieti
viral
veli
transfer
activ
antigenspecif
cell
line
peptid
eau
induc
immun
cyclosporin
csa
shown
small
synthet
peptid
correspond
amino
acid
posit
effect
prevent
eau
suggest
pathogen
role
yeast
histon
thu
molecular
mimicri
activ
cell
diseas
eau
therefor
propos
mechan
initi
andor
perpetuatus
model
determin
like
cellmedi
effector
ing
eauc
mechan
within
retina
aim
review
chronicrelapsingeaewasinitiallydescribedinguineapig
compar
find
obtain
eau
eae
use
spinal
cord
homogen
emulsifi
fca
diseas
anoth
model
cellmedi
autoimmun
find
subsequ
induc
rang
speci
myelin
diseas
occur
socal
immunologicallybas
protein
mbp
extract
white
matter
studi
use
privileg
site
similar
effector
cell
mechan
synthesis
peptid
mbp
reveal
encephalitogen
site
molecul
recent
central
nervou
system
cn
antigen
also
shown
encephalitogen
correspond
dr
v
calder
depart
clinic
scienc
eg
proteolipid
protein
molecular
mimicri
institut
ophthalmolog
cayton
street
london
implic
eae
due
find
mani
viral
infect
uk
includ
measl
coronaviru
jhm
increas
sensit
mbp
homolog
sequenc
class
ii
molecul
seen
eae
infiltr
perivascuidentifi
viral
peptid
mbp
lar
cell
mhc
class
iiexpress
cell
predomin
altern
method
induc
eae
eau
lesion
within
white
matter
central
nervou
demonstr
use
adopt
transfer
techniqu
immunizsystem
suggest
cell
mediat
ing
suffici
number
activ
antigenspecif
demyelin
variou
effector
cell
mechan
might
util
lymph
node
cell
sagprim
rat
initi
occur
eae
eau
examin
vivo
uveiti
associ
pineal
induct
eae
use
moab
recogn
cell
subset
lymphokin
rat
method
demonstr
use
lymph
node
cell
attempt
alter
cours
diseas
thu
eae
mice
reactiv
mbp
induc
chronic
demyelin
diseas
prevent
use
either
anticlass
ii
moab
exactli
cell
inject
periph
similarli
eau
uveiti
rat
inhibit
alli
induc
organspecif
diseas
remain
unclear
studi
antiia
moab
contrast
chang
use
radioisotop
label
follow
migrat
ofth
cell
seen
cours
diseas
lewi
rat
deplet
adopt
transfer
eau
lewi
rat
found
cell
induc
eae
although
cell
label
cell
cross
bloodretin
barrier
brb
identifi
later
stage
diseas
eye
techniqu
previous
use
eae
suggest
cell
play
import
role
examin
traffick
lymphocyt
cn
across
initi
downregul
eae
similar
studi
treat
rat
bloodbrain
barrier
bbb
increas
accumul
moab
induc
eau
fail
alter
cell
detect
within
cn
onset
diseas
cours
diseas
suggest
cell
thu
clonal
expans
inocul
autoreact
cell
import
regul
eau
within
tissu
suggest
amplif
antilymphokin
antibodi
also
prevent
diseas
mechan
wherebi
cell
induc
eae
eau
recent
report
success
prevent
eau
lewi
rat
syngen
host
compar
method
induc
antiinterferongamma
ifni
antibodi
demonstr
eau
eae
appear
model
similar
import
lymphokin
pathogenesi
eau
immunolog
mechan
involv
molecular
lewi
rat
eae
recent
shown
illh
mimicri
implic
due
region
homolog
treatment
exacerb
diseas
suppress
diseas
share
relev
autoantigen
variou
peptid
obtain
treatment
solubl
ili
receptor
anoth
lymphokin
found
play
import
role
downregul
chronic
relaps
eae
mice
transform
growth
factorfl
although
role
eau
unclear
model
eau
develop
guinea
pig
rat
recent
detect
high
concentr
normal
aqueou
rabbit
mice
although
uveitogen
respons
within
humor
sever
differ
mammalian
speci
speci
vari
strain
rat
pvg
lewi
suscept
diseas
other
mice
eau
immunotherapi
recent
achiev
induct
requir
use
irbp
oppos
sag
appear
poorli
follow
success
adopt
transfer
method
uveitogen
speci
eae
mani
speci
induc
eae
activ
cell
demonstr
suscept
diseas
rat
lewi
mous
sjl
cell
inocul
rat
subencephaliplj
strain
suscept
other
sever
togen
dose
abl
confer
protect
subsequ
studi
attempt
map
respons
mhc
class
attack
eae
approach
also
success
ii
gene
mous
found
genet
predisposivaccin
rat
eau
mechan
wherebi
tion
eae
partli
depend
q
haplotyp
cell
vaccin
prevent
diseas
thought
occur
initi
rat
lewi
strain
suscept
eae
rtli
locu
immun
respons
endogen
clone
lymphocyt
wherea
bn
strain
resist
rtln
suggest
antimbp
receptor
enhanc
suppress
mhc
class
ii
gene
control
cell
respons
mbp
altern
method
downregul
diseas
dehenc
diseas
suscept
howev
pvg
rat
scribe
eau
use
suppressor
cell
line
rel
resist
eae
respond
mbp
peptid
one
effect
immunotherapi
eae
peptideth
suscept
lewi
rat
suggest
mhc
class
ii
gene
specif
prevent
diseas
neonat
toler
factor
involv
diseas
suscept
immunodomin
peptid
mbp
adult
mice
subseconclus
compar
eau
eae
mani
quentli
made
resist
eae
known
form
speci
suscept
diseas
although
requireof
immunotherapi
effect
eau
anoth
success
ment
genet
predisposit
remain
unclear
approach
immun
peptid
select
evid
diseas
sinc
clear
basi
abil
bind
class
ii
molecul
prevent
whilst
pvg
rat
highli
suscept
eau
eae
block
class
iimedi
process
molecular
true
eae
studi
dna
rearrang
cell
receptor
variabl
v
gene
indic
encephalitogen
cell
immunopathogenesislin
share
high
degre
homolog
suggest
immunopathogenesist
cell
respons
eae
polyclon
one
form
immunopatholog
eau
similar
eae
immunotherapi
might
use
peptid
bind
earli
stage
diseas
within
retina
eau
larg
number
block
antigen
recognit
site
cell
receptor
prevent
infiltr
cell
increas
local
express
diseas
use
approach
report
rat
render
resist
induct
eae
vaccin
synthet
peptid
repres
hypervari
region
cell
receptor
tcr
molecul
uveitogen
cell
line
examin
cell
receptor
v
gene
found
cell
enrich
vfl
whether
peptid
synthesis
cell
receptor
v
gene
protect
rat
eau
yet
demonstr
interestingli
oral
immun
shown
effect
prevent
eae
eau
feed
rat
mbp
sag
result
markedli
diminish
enceph
uveiti
precis
mechan
involv
immunosuppress
remain
unclear
although
effect
could
revers
treat
rat
moab
conclus
immunotherapeut
approach
perform
eau
eae
immunolog
differ
result
could
found
therefor
surpris
immunosuppress
drug
csa
effect
prevent
eae
eau
revers
diseas
eae
perivascular
inflammatori
infiltr
lead
damag
ofth
myelin
sheath
surround
nerv
although
myelinproduc
oligodendrocyt
remyelin
contrast
eau
damag
photoreceptor
cell
irrevers
cell
regener
despit
differ
cours
diseas
neither
photoreceptor
cell
oligodendrocyt
express
class
ii
molecul
vivo
vitro
seem
contradict
theori
aberr
express
class
ii
molecul
target
cell
lead
perpetu
chronic
inflammatori
diseas
perhap
oligodendrocyt
photoreceptor
cell
damag
bystand
effect
effector
cell
respons
mhc
class
ii
molecul
necessari
recognit
cell
detect
within
retina
eau
retin
endotheli
cell
pigment
epitheli
cell
although
find
disput
other
eae
class
ii
express
seen
within
lesion
particularli
perivascular
cell
level
class
ii
induct
also
demonstr
vitro
brainderiv
endotheli
cell
microglia
type
astrocyt
oligodendrocyt
suggest
lack
express
class
ii
molecul
target
cell
necessarili
prevent
damag
cell
respons
bloodretin
barrier
eae
eau
success
adopt
transfer
diseas
requir
cell
activ
found
activ
cell
produc
enzym
capabl
degrad
extracellular
matrix
also
recent
shown
activ
cell
cross
bbb
presum
brb
exactli
cell
cross
bbb
brb
blood
remain
unclear
adhes
molecul
thought
import
upregul
adhes
molecul
report
within
cn
coincid
onset
relaps
eae
support
role
receptormedi
migrat
cell
brain
cultur
cerebrovascular
endotheli
cell
lewi
rat
shown
adhes
activ
rest
lymphocyt
thought
involv
complex
adhes
molecul
sinc
adhes
could
select
inhibit
antibodi
studi
done
rat
retin
endotheli
cell
human
retin
endotheli
cell
human
pigment
epitheli
cell
found
express
high
level
icami
follow
incub
ifni
although
bbb
brb
appear
similar
function
rat
man
one
import
differ
abil
csa
downregul
diseas
man
csa
poorli
effect
treatment
multipl
sclerosi
enter
brain
detect
amount
contrast
csa
effect
treatment
posterior
uveiti
man
suggest
either
exert
effect
peripher
level
reduc
number
cell
recruit
site
inflamm
cross
brb
local
suppress
cell
respons
evid
low
level
csa
cross
brb
uveiti
man
support
latter
hypothesi
conclus
studi
carri
far
eau
eae
seem
involv
similar
immunolog
process
diseas
induct
cytokin
produc
appropri
target
molecul
immunotherapi
unabl
identifi
immunolog
differ
either
induct
express
diseas
eau
eae
differ
exist
mainli
result
anatom
differ
brain
eye
sinc
model
autoantigen
local
within
target
organ
autoreact
cell
could
attract
site
inflamm
although
clear
either
model
autoreact
cell
expand
cross
relev
barrier
two
model
cellmedi
autoimmun
share
mani
common
immunolog
featur
although
relev
human
diseas
limit
evid
mbp
sag
autoantigen
human
diseas
question
sinc
lymphocyt
respons
antigen
detect
blood
control
nevertheless
model
clearli
great
import
allow
understand
variou
autoreact
cell
mechan
